Genetic polymorphisms and spontaneous preterm birth

dc.contributor.authorGibson, C.
dc.contributor.authorMacLennan, A.
dc.contributor.authorDekker, G.
dc.contributor.authorGoldwater, P.
dc.contributor.authorDambrosia, J.
dc.contributor.authorMunroe, D.
dc.contributor.authorTsang, S.
dc.contributor.authorStewart, C.
dc.contributor.authorNelson, K.
dc.date.issued2007
dc.description© 2007 by The American College of Obstetricians and Gynecologists
dc.description.abstract<h4>Objective</h4>To examine whether selected genetic polymorphisms in the infant are associated with spontaneous preterm birth (less than 37 weeks) among children with or without later-diagnosed cerebral palsy.<h4>Methods</h4>Exploratory case-control study investigating the relationship of gestational age at delivery to 31 single nucleotide polymorphisms measured in newborn screening bloodspots. Among all 443 children with later-diagnosed cerebral palsy born to white women in South Australia in 1986-1999, 234 were born after spontaneous onset of labor, and 108 of these were preterm (gestational age less than 37 weeks). The comparison group was 549 infants born after spontaneous onset of labor, of whom 147 were preterm. Distributions of genotypic frequencies were examined in preterm compared with term infants with and without cerebral palsy. Genotyping was performed using a Taqman assay.<h4>Results</h4>In children without cerebral palsy, preterm birth after spontaneous onset of labor was more frequent in association with a variant of the beta2 adrenergic receptor gene (ADRB2 Q27E, P=.003), inducible nitric oxide synthase (iNOS or NOS2A, P=.042), or thrombomodulin (G127A, P=.006). Among children with cerebral palsy, preterm birth was associated with polymorphisms in genes for endothelial nitric oxide synthase (eNOS -922, P=.012), plasminogen activator inhibitor-2 (P=.015 and .019), and alpha adducin (ADD1, P=.047).<h4>Conclusion</h4>We confirm previous observations that variants of the beta adrenergic receptor and of nitric oxide synthase are associated with prematurity, and suggest that genetic variants of the placental antifibrinolytic plasminogen activator inhibitor-2, and thrombomodulin and alpha adducin may be contributors to risk of spontaneous preterm birth.<h4>Level of evidence</h4>II.
dc.description.statementofresponsibilityCatherine S. Gibson, Alastair H. MacLennan, Gustaaf A. Dekker, Paul N. Goldwater, James M. Dambrosia, David J. Munroe, Shirley Tsang, Claudia Stewart, Karin B. Nelson
dc.description.urihttp://www.ncbi.nlm.nih.gov/pubmed/17267840
dc.identifier.citationObstetrics and Gynecology, 2007; 109(2 Part 1):384-391
dc.identifier.doi10.1097/01.AOG.0000252712.62241.1a
dc.identifier.issn0029-7844
dc.identifier.issn1873-233X
dc.identifier.orcidDekker, G. [0000-0002-7362-6683]
dc.identifier.orcidGoldwater, P. [0000-0003-4822-8488]
dc.identifier.urihttp://hdl.handle.net/2440/41471
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.source.urihttps://doi.org/10.1097/01.aog.0000252712.62241.1a
dc.subjectHumans
dc.subjectCerebral Palsy
dc.subjectPremature Birth
dc.subjectInfant, Premature, Diseases
dc.subjectCase-Control Studies
dc.subjectGestational Age
dc.subjectPregnancy
dc.subjectPolymorphism, Single Nucleotide
dc.subjectInfant, Newborn
dc.subjectInfant, Premature
dc.subjectSouth Australia
dc.subjectFemale
dc.subjectMale
dc.subjectWhite People
dc.titleGenetic polymorphisms and spontaneous preterm birth
dc.typeJournal article
pubs.publication-statusPublished

Files